Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Johnson and Johnson
Baxter
McKinsey

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Ibuprofen; oxycodone hydrochloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for ibuprofen; oxycodone hydrochloride and what is the scope of patent protection?

Ibuprofen; oxycodone hydrochloride is the generic ingredient in two branded drugs marketed by Forest Labs, Actavis Elizabeth, Barr Labs Inc, and Watson Labs, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-four drug master file entries for ibuprofen; oxycodone hydrochloride. One supplier is listed for this compound.

Recent Clinical Trials for ibuprofen; oxycodone hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Northwestern UniversityPhase 4
Milton S. Hershey Medical CenterPhase 3
CMC Ambroise ParéPhase 3

See all ibuprofen; oxycodone hydrochloride clinical trials

Recent Litigation for ibuprofen; oxycodone hydrochloride

Identify potential future generic entrants

District Court Litigation
Case NameDate
Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.2015-09-15
Endo Pharmaceuticals Inc. v. Actavis Inc.2012-12-11
Endo Pharmaceuticals Inc. v. Impax Laboratories Inc.2007-11-15

See all ibuprofen; oxycodone hydrochloride litigation

Pharmacology for ibuprofen; oxycodone hydrochloride

US Patents and Regulatory Information for ibuprofen; oxycodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs OXYCODONE HYDROCHLORIDE AND IBUPROFEN ibuprofen; oxycodone hydrochloride TABLET;ORAL 078394-001 Nov 26, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
Actavis Elizabeth OXYCODONE HYDROCHLORIDE AND IBUPROFEN ibuprofen; oxycodone hydrochloride TABLET;ORAL 078769-001 Jan 4, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Barr Labs Inc OXYCODONE HYDROCHLORIDE AND IBUPROFEN ibuprofen; oxycodone hydrochloride TABLET;ORAL 078316-001 Nov 29, 2007 AB RX No Yes   Start Trial   Start Trial   Start Trial
Forest Labs COMBUNOX ibuprofen; oxycodone hydrochloride TABLET;ORAL 021378-001 Nov 26, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Merck
Harvard Business School
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.